# Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

> **NCT00002833** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 53 (actual)

## Conditions studied

- Graft Versus Host Disease
- Leukemia
- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** Filgrastim
- **DRUG:** Cladribine
- **DRUG:** Cyclosporine
- **DRUG:** Cytarabine (Ara-C)
- **DRUG:** Fludarabine Phosphate
- **DRUG:** Idarubicin
- **DRUG:** Methylprednisolone
- **PROCEDURE:** Peripheral Blood Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT00002833
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-10
- **Primary completion:** 2002-04
- **Final completion:** 2002-04
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2012-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002833, "Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00002833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*